订阅小程序
旧版功能

The Efficacy and Safety of Cadonilimab Combined with Lenvatinib for First-Line Treatment of Advanced Hepatocellular Carcinoma (COMPASSION-08): a Phase Ib/II Single-Arm Clinical Trial

Frontiers in Immunology(2023)

引用 7|浏览49
关键词
cadonilimab,lenvatinib,BsA,bi-specific antibody,hepatocellular carcinoma,HCC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要